Showing results (111-120 of 262) with videos related to
Sort By:
Pageof 27
Blood|June 25, 1998
Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cellsU Döbbeling, R Dummer, E Laine, et al.Immunitat Und Infektion|April 1, 1992
[Shedding of soluble intercellular adhesion molecule 1 (ICAM-1) from melanoma cells and the effect on cellular cytotoxicity]J C Becker, R Dummer, R E Schmidt, et al.Dermatology (Basel, Switzerland)|July 17, 2001
Skin cancers in organ transplant recipients: two cases of virus-induced neoplasmsG F Hofbauer, R Dummer, J Hafner, et al.The American Journal of Pathology|May 5, 2001
Differential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8+ and CD56+ cutaneous lymphomasJ Kamarashev, G Burg, M C Mingari, et al.Gene Therapy|March 21, 2003
A novel attenuated replication-competent adenovirus for melanoma therapyI Peter, C Graf, R Dummer, et al.British Journal of Cancer|January 1, 1995
Interleukin 2-induced increase of vascular permeability without decrease of the intravascular albumin poolB K Ballmer-Weber, R Dummer, E Küng, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1991
Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicityJ C Becker, R Dummer, A A Hartmann, et al.The British Journal of Dermatology|April 1, 1993
T cells migrate to tumour sites after extracorporeal interleukin 2 stimulation and reinfusion in a patient with metastatic melanomaR Dummer, J C Becker, C Eilles, et al.Cancer Research|February 24, 2001
Coexpression of CD40 and CD40 ligand in cutaneous T-cell lymphoma (mycosis fungoides)M Storz, K Zepter, J Kamarashev, et al.European Journal of Nuclear Medicine|January 1, 1991
Imaging pattern of radiolabelled lymphokine-activated killer cells in patients with metastatic malignant melanomaE Schäfer, R Dummer, C Eilles, et al.Pageof 27